Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.
132 results about "Intracellular pH" patented technology
Filter
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Intracellular pH (pHi) is the measure of the acidity or basicity (i.e., pH) of intracellular fluid. The pHi plays a critical role in membrane transport and other intracellular processes. In an environment with the improper pHi, biological cells may have compromised function. Therefore, pHi is closely regulated in order to ensure proper cellular function, controlled cell growth, and normal cellular processes. The mechanisms that regulate pHi are usually considered to be plasma membrane transporters of which two main types exist — those that are dependent and those that are independent of HCO⁻₃. Physiologically normal intracellular pH is most commonly between 7.0 and 7.4, though there is variability between tissues (e.g., mammalian skeletal muscle tends to have a pHi of 6.8-7.1).. There is also pH variation across different organelles, which can span from around 4.5 to 8.0. pHi can be measured in a number of different ways.
The present invention provides methods, instruments, reagents, kits and the biology involved in analyzing drug response. An embodiment of the present invention provides an approach for the characterization a plurality of pathways in single cells. This approach permits the rapid detection of heterogeneity in a complex cellpopulation based on activation states of cellular molecules such as proteins, expression markers and other criteria, and the identification of cellular subsets that exhibit correlated changes in activation within the cellpopulation. Some of these categories include redox potential, ITIM phosphorylation, intracellular pH and other categories allows for characterization of such pathways and cell populations. Also, the present analysis is useful for the analysis of the effect of compounds on potential target cells.
Methods and compositions are provided for analyzing intracellular events employing fusion proteins comprising the small beta-galactosidase fragment fused to a protein of interest or fragment thereof. By expressing the fusion protein in a cellular host, one can determine the effect of various agents on the activity of the fusion protein, adding the large beta-galactosidase fragment to the fusion protein, either intracellularly or in a lysate and determining the activity of the formed beta-galactosidase using a substrate that forms a detectable product. In this manner, degradation, complex formation, RNAi inhibition or other situation that affects beta-galactosidase activity can be determined.
The invention discloses novel application of a cyanine dye to viable cell mitochondria G-quadruplex detection. The cyanine dye is a structural compound shown as a formula (I) or a stereoisomer of thecompound shown as the formula (I). A cyanine dye fluorescent probe has advantages of high biocompatibility, low cytotoxicity, low molecular weight and low biological sample damages, and real-time observation of cell samples can be realized without being affected by pH values of cells.
The invention discloses a NF-kappa B specifically activated geneexpression vector and application thereof. A gene expression technique is implemented by the NF-kappa B specifically activated geneexpression vector. The gene expression vector contains two elements, i.e., a regulatory gene-expressed promoter sequence and a promoter downstream effect gene coding sequence, wherein the promoter sequence consist of a section of NF-kappa B response sequence and a minimal promoter sequence. After the gene expression vector is introduced into NF-kappa B overactivated cells, an effect gene on the vector is expressed under the activation of a sequence-specific transcription factor NF-kappa B, and the effect gene generates influence on cellphysiology, such as cellgrowth inhibition, apoptosis and death. The gene expression technique provided by the invention can be used for treating diseases related to NF-kappa B overactivation, such as inflammation and cancers. The gene expression vector constructed by the invention can be used in the preparation of gene therapy reagents and drugs for treating diseases related to NF-kappa B overactivation.
The invention provides adriamycin nano-particles. The adriamycin nano-particles are prepared by compounding adriamycin and a block copolymer with a structure shown as a formula (I) or a formula (II) through electrostatic interaction. A preparation method for the adriamycin nano-particles comprises the following step of: electrostatically compounding the adriamycin and the block copolymer with thestructure shown as the formula (I) or the formula (II) in an aqueous medium to obtain the adriamycin nano-particles. In the aqueous medium, a poly(gamma-propargyl-L-glutamate-g-mercaptosuccinic acid)segment and a polyethylene glycol segment which are contained in the block copolymer wrap the adriamycin into cores of the nano-particles, so the adriamycin composite particles are high in stability.The nano-particles are expected to be gathered at tumor sites in blood circulation through an 'enhanced permeability and retention effect' so as to improve the targeting effect of the adriamycin on the tumor sites. Meanwhile, the electrostatic interaction between a carboxyl group of the block copolymer and an amino group of the adriamycin is easy to eliminate under the condition of low intracellular pH values, so that the intracellular release can be accelerated, and the medicinal effect can be improved.
The invention discloses a method for complete cryopreservation and thawing of an RNC (intracellularribosome nascent-chain complex). The method comprises the following steps: adding a translation elongation inhibitor into cellculture fluid in normal growth, cooling cells to the temperature of 0-4 DEG C after the translation elongation inhibitor effectively acts on the RNC and translation elongation is inhibited, cleaning the cells by using a PBS solution which is precooled to the temperature of 0-4 DEG C, adding the PBS solution into the cells, rapidly freezing in liquid nitrogen, preserving at an ultra-low temperature, thawing on ice, and extracting the RNC. According to the method, ribosome is effectively fixed by adopting the translation elongation inhibitor and is unlikely to dissociate, and the translation conditions in the cells are fixed. Moreover, the RNC is effectively cryopreserved for long-term storage and transport through a liquid nitrogenquick freezing method, and the extracted RNC after thawing is the same as the RNC extracted from fresh cells, so the limitation of time and space is broken through, and convenience is provided for research of the RNC and development of commercial service of the RNC.
The invention relates to a rare earth fluorescent signal based quantitative detection method of HPA (hydroxyapatite) nano particles, and the quantitative detection method is characterized by comprising the following steps: 1) formulating a europiumionfluorescence-concentration standard curve; 2) establishing dissolution rate of calcium ions and europium ions in the HPA (hydroxyapatite) nano particles, and determining the accuracy of a fluorescence-concentration standard curve method; 3) quantitatively detecting intracellular HAP nano particles; and 4) tracing a dissolution course of the intracellular HAP nano particles. The main advantages of the quantitative detection method are that: 1) the quantitative detection method is good in biocompatibility, safe and reliable, and is free of radioactive labeling using condition limitation problems; 2) the quantitative detection method is low in the detection limit, the detection limit concentration can reach 0.5nM, and the sample needing amount is less; and 3) the quantitative detection method can more accurately shown dissolution of the intracellular HAP nano particles, and the compatibility of the dissolving out of the europium ions and the dissolution of the HAP nano particles is high.
Non-aggregating resorbable calcium phosphosilicate nanoparticles (CPNPs) are bioconjugated to targeting molecules that are specific for particular cells. The CPNPs are stable particles at normal physiological pH. Chemotherapy and imaging agents may be integrally formed with the CPNPs so that they are compartmentalized within the CPNPs. In this manner, the agents are protected from interaction with the environment at normal physiological pH. However, once the CPNPs have been taken up, at intracellular pH, the CPNPs dissolve releasing the agent. Thus, chemotherapeutic or imaging agents are delivered to specific cells and permit the treatment and / or imaging of those cells. Use of the bioconjugated CPNPs both limits the amount of systemic exposure to the agent and delivers a higher concentration of the agent to the cell. The methods and principals of bioconjugating CPNPs are taught by examples of bioconjugation of targeting molecules for breast cancer, pancreatic cancer, and leukemia.
The invention relates to a phenyl quinoline derivative iridium (III) complex based on piperidine or morpholinemethylene substitution, and relates to the technical field of organic photoelectric materials. The complex is composed of a cyclometalated C^N bidentate ligand substituted by piperidine or morpholine through methylene connection, central metaliridium (III) ion and 2,2'-bipyridyl. The complex has a structural general formula as the following. According to the invention, a piperidine or morpholinemethylene-substituted phenyl quinoline derivative C^N bidentate ligand is subjected to a reaction with iridium trichloride trihydrate, such that a iridium (III) chloro-bridged dimer with a corresponding ligand is obtained; the dimer is further subjected to a reaction with 2,2'-bipyridyl; and the complex is prepared through ion exchange. The iridium (III) complex provided by the invention has a good application prospect in the fields of intracellular pH value testing, imaging and marking.
The invention relates to the field of single cell detection, in particular to an intracellular pH value (pHi) detection method. The method comprises the following steps: (1) co-incubating to-be-detected cells with a cell membrane-permeable and pH-sensitive fluorescent dye, and putting the to-be-detected cells loaded with the fluorescent dye into a buffer solution in an air and temperature controldevice; with the assistance of a perfusion / drugdelivery system, using a device capable of monitoring the fluorescence change of cells in real time to record the cellfluorescence intensity data corresponding to different treatments; (2) treating the cells with calibration solutions of different known pH values, establishing a standard curve of cell fluorescence intensity-cell pHi related data, and substituting cell fluorescence intensity data into the standard curve to obtain a single cell pHi. The method can monitor the change of pHi of single or multiple cells for a long time and in real time without damaging the cells, has good reproducibility, and is suitable for detecting the pH of cells of various sizes.
The invention discloses a preparation method of an antitumor micelle containing adriamycin. The preparation method comprises the following steps: polymerizing acrylic acid by utilizing an atom transfer radical polymerization method, thus obtaining polyacrylic acid; modifying polyacrylic acid by utilizing folic acid molecules; polymerizing glutamic acid benzyl ester carboxylic acid anhydride by utilizing a ring opening polymerization method, thus obtaining polyglutamic acid benzyl ester; grafting adriamycin onto polyglutamic acid benzyl ester via hydrazone bonds; connecting polyacrylic acid with polyglutamic acid benzyl ester with bonds through click chemistry, thus obtaining block copolymers; after dissolving the block copolymers in tetrahydrofuran respectively, transferring the solutions into a dialysis bag, dialyzing the solutions with pure water, and filtering the dialysate with a filter membrane; freeze-drying the solutions after filtration, thus obtaining a drug loading micelle. The drug carrier micelle has a core / shell double-layer structure, wherein the outer layer is formed by hydrophilic polyacrylic acid, and the inner layer is a drug molecule coated layer. The material has the advantages that the material belongs to nanoparticles; the drug can achieve targeting delivery of cancer cells and pH-sensitive release in the cancer cells; the material has high drug loading capacity and good stability; the toxic and side effects of the drug on normal tissues and organs can be effectively reduced via the targeting function of the drug.
The invention relates to a fluorescent probe for intracellular Hg<2+> detection by using oxygen atoms as combination sites. The invention relates to an Hg<2+> fluorescent molecular probe in the field of fine chemicalengineering. The probe is prepared by reacting rhodamine fluorescent dyes with amino acids and phthalic anhydride. The excitation and emission wavelengths are in the visible light region. The pH value is 5-8, the probe has favorable selectivity for Hg<2+>, the detection can not be influenced by Mg<2+>, Mn<2+>, Fe<3+>, Ca<2+>, Zn<2+>, Ag<+> and other metallic ions, and the probe can detect Hg<2+> with micromole concentration. The cell imaging experiment indicates that the probe has favorable permeability for HL-7702 cells and various other cells or tissues, has no toxic or side effect on the cells and is especially suitable for detecting intracellular Hg<2+> concentration changes and distribution.
The invention provides a fluorescent cell model for screening an M2 ionchannel blocker for influenza virus, and the cell model is a cell containing pH sensitive fluorescent materials. Meanwhile, the invention also provides a method for screening the M2 ionchannel blocker for the influenza virus by the cell model, which is to detect the change of fluorescent values in the cell model under the condition of an acidic buffer. The invention has the advantages that the H+ flowing condition through the M2 ion channel is directly reflected by detecting the change of the fluorescent values reflecting pH in the cell; and the M2 ion channel blocker screening method established by the cell model has definite mechanism of drug action, is simple and convenient, quick and direct, and is suitable for high-flux accurate screening of the M2 ion channel blocker.